Additionally, OGT-mediated O-glycosylation promotes chemoresistance in CRC by stabilizing ADAR, which enhances its A-to-I editing activity on downstream targets like PARP1, thereby upregulating DNA repair capability [77]. The gene discussed is ADAR; the disease is colorectal carcinoma.